Unlike fenretinide, another RBP4 antagonist, A1120 is neither a retinoid nor an agonist to RARα, the property of which may avoid the retinoids‐associated side effects, such as nyctalopia and delayed dark adaptation.37 The gene discussed is RBP4; the disease is night blindness.